Mark Neumann - Net Worth and Insider Trading
Mark Neumann Net Worth
The estimated net worth of Mark Neumann is at least $3 Million dollars as of 2024-11-05. Mark Neumann is the EVP, Chief Commercial Officer of Intra-Cellular Therapies Inc and owns about 29,700 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $3 Million. Details can be seen in Mark Neumann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Neumann has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Neumann
Mark Neumann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Neumann owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Mark Neumann’s form 4 insider trades.
Insider Ownership Summary of Mark Neumann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-08-16 | EVP & Chief Commercial Officer |
Mark Neumann Latest Holdings Summary
Mark Neumann currently owns a total of 1 stock. Mark Neumann owns 29,700 shares of Intra-Cellular Therapies Inc (ITCI) as of August 16, 2024, with a value of $3 Million.
Latest Holdings of Mark Neumann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-08-16 | 29,700 | 89.23 | 2,650,131 |
Holding Weightings of Mark Neumann
Mark Neumann Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Neumann has made a total of 19 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 18,714 shares on August 16, 2024, which brought Mark Neumann around $1 Million.
Insider Trading History of Mark Neumann
- 1
Mark Neumann Trading Performance
Mark Neumann Ownership Network
Ownership Network List of Mark Neumann
Ownership Network Relation of Mark Neumann
Mark Neumann Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Mark Neumann is the EVP & Chief Commercial Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , Chief Medical Officer Suresh K. Durgam , and VP of Finance & CFO & Secretary Lawrence J. Hineline .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Mark Neumann made 6 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 156,651. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 105,827 shares made by Suresh K. Durgam , and a net sale of 140,244 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Mark Neumann Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Neumann. You might contact Mark Neumann via mailing address: C/o Intra-cellular Therapies, Inc., 430 East 29th Street, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
